Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 28/01/2025 |
| פקולטה | Exact Sciences, Life Sciences, Medicine |
| תיאור | The purpose of this grant is to support milestone-driven, early-stage translational research focused on drug discovery and development of novel therapeutics against select fungal pathogens including: Candida species, specifically Candida auris; Aspergillus fumigatus; Coccidioides; and Mucorales. \
Funding: R21 $275,000 total; R33 $200,000 per year Duration: R21 2 years; R33 3 years
Research Authority due date: 19.12.24 LOI (encouraged) due date: 28.12.24 Full application due date: 28.1.25 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 30/09/2024 |
